Atara Biotherapeutics(CH:ATRA)
CH:ATRA
Atara Biotherapeutics earnings date
Atara Biotherapeutics (ATRA) Q3 2023 Earnings Report
0 Followers
CH:ATRA Q3 2023 EPS Results
- Actual EPS
- -CHF 13.73
- Consensus EPS
- -CHF 12.96
- Beat/Miss
- Missed by -CHF 0.77
- One Year Ago EPS
- -CHF 17.06
CH:ATRA Q3 2023 Revenue Results
- Actual Revenue
- CHF 1.78M
- Expected Revenue
- CHF 4.24M
- Beat/Miss
- Missed by -CHF 2.46M
- YoY Revenue Growth
- -52.05%
Earnings Announcement Details
- Quarter
- Q3 2023
- Date
- 11/01/2023
- Time
- Before Open
- Conference Call
- Wednesday, November 1, 2023
CH:ATRA Upcoming Earnings
Atara Biotherapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q3 2023 Earnings Call Audio
CH:ATRA Q3 2023 Earnings Call
0:00 / 0:00
Q3 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:ATRA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | -0.08- | -0.21 | ― | ― |
| Nov 10, 2026 | 2026 (Q3) | -0.11-0.12 | -0.27 | 53.13% (+0.14) | |
| Aug 12, 2026 | 2026 (Q2) | -0.26-0.27 | 0.16 | -268.42% (-0.42) | |
| May 12, 2026 | 2026 (Q1) | -0.27-0.24 | 2.91 | -108.29% (-3.15) | |
| Mar 16, 2026 | 2025 (Q4) | -0.15-0.21 | -0.99 | 78.99% (+0.78) | |
| Nov 29, 2025 | 2025 (Q3) | -0.55-0.27 | -2.44 | 89.08% (+2.17) | |
| Aug 11, 2025 | 2025 (Q2) | -0.050.16 | -2.58 | 106.13% (+2.74) | |
| May 15, 2025 | 2025 (Q1) | -1.652.91 | -4.79 | 160.87% (+7.70) | |
| Mar 07, 2025 | 2024 (Q4) | -2.38-0.99 | -11.65 | 91.50% (+10.66) | |
| Nov 12, 2024 | 2024 (Q3) | -1.57-2.44 | -13.73 | 82.24% (+11.29) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
